Schlagwort: clinical data.
Part III: The Best Asset Doesn’t Have a Passport
For many years, Western biotech companies viewed China primarily as a manufacturing base and, increasingly, as an attractive commercial market. Today, that perspective is...
Immunic Therapeutics
Immunic steht vor einer entscheidenden Phase seiner Unternehmensgeschichte. Nach Jahren intensiver Forschung rückt nun der Übergang vom klassischen Forschungs- und Entwicklungsunternehmen hin zu einem...
A trimmed biotech basket
Following a strong performance in the summer period, shares of German biotech companies were affected by another global downward trend. We have adjusted the...



